Evidence map›Paper›PMID 36457508›Full record

ArticleFrontiers in oncology2022

Corrigendum: Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma.

Yun Liu, Wenyu Feng, Yan Dai, Mengying Bao, Zhenchao Yuan, Mingwei He, Zhaojie Qin, Shijie Liao, Juliang He, Qian Huang and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Yun LiuDepartment of Spinal Bone Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wenyu FengDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yan DaiCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Mengying BaoCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Zhenchao YuanDepartment of Bone and Soft Tissue Surgery, The Affiliated Tumor Hospital, Guangxi Medical University, Nanning, China.
Mingwei HeDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhaojie QinDepartment of Spinal Bone Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Shijie LiaoDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Juliang HeDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qian HuangDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhenyuan YuCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Yanyu ZengCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Binqian GuoCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Rong HuangCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Rirong YangCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Yonghua JiangCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Jinling LiaoCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Zengming XiaoDepartment of Spinal Bone Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xinli ZhanDepartment of Spinal Bone Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Chengsen LinDepartment of Trauma Orthopedic and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiake XuSchool of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia.
Yu YeCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
Jie MaDepartment of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qingjun WeiDepartment of Spinal Bone Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zengnan MoCenter for Genomic and Personalized Medicine, School of Preclinical Medicine, Guangxi Medical University, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.709210.].

Indexed as

heterogeneitynaive osteosarcomaosteolysissingle-cell RNA sequencingtumor microenvironment

Identifiers

PMID36457508
PMCPMC9707623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.